Literatura
Kontakt Forum RSS
Ginekologija
Brojni znanstvenici istražuju uzroke, a drugi nastoje pronaći brzu i učinkovitu pomoć za liječenje ginekoloških oboljenja. Većina njih usmjerena je na tjelesne smetnje, dok je manje učinjeno na razjašnjenju psiholoških mehanizama povezanih s ovim tegobama.

Literatura

Vezano
Datum zadnje izmjene: 6. siječnja 2017.





Coco AS.
Primary dysmenorrhea. Am Fam Physician 1999; 60 (29): 489-96

Kennedy S. Primary dysmenorrhea. The Lancet 1997; 349:1116

French L. Dysmenorrhea. Am Fam Phyician 2005; 71 (2):285-91

Reddish S.
Dysmenorrhoea. Aus Fam Physician 2006; 35 (11):842-9

SOGC Clinical Practice Guideline.
Primary Dysmenorrhea Consesus Guideline. JOGC 2005 (12):1119-20

Juang CM; Yen MS, Horng HC et al. Natural progression of menstrual pain in nulliparous women at reproductive age: an observational study. J Chin Med Assox 2006; 69 (10): 484-8

Dawood MY. Dysmenorrea and prostaglandins: Pharmacological and therapeutic consideration. Drugs 1981; 22-42

Benedetto C. Eicosanoids in primary dysmenorrea, endometriosis and menstrual mifraine. Fynecol Endocrinol 1989; 3:71-94

Heitkemper MM, Shaver JF, Mitchell ES. Gastrointestinal symptoms and bowel patterns across the menstrual cycle in dysmenorrhea. Nurs Res 1988; 37 (2): 108-13

Dawood MY; Khan-Dawood FS. Clinical efficacy and differentioan inhibition of menstrual fluid prostaglandin F2alpha in a randomized, double-blind, crossover treatment with placebo, acetaminophen and ibuprofen in primary dysmenorrhea. Am J Obstet Gynecol 2007; 196 (1):35.e1-5

Coakley FV, Varghese SL, Hricak H.
CT and MRI of Pelvic Varices in Women. Journal of Computer Assisted Tomography. 1999; 23(3):429-34

Wood C. Advances in the treatment of menstrual disorders. Current Therapeutics 2000; 41:42-7

Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea (Cochrane Review). The Cochrane Database of Systemic Reviews 2003; CD001751

Milsom I, Minic M, Dawood MY et al.
Comparison of the efficacy and safety of non-prescription doses of naproxen sodium with ibuprofen, acetaminophen and placebo in the treatment of primary dysmenorrhoea: a ppled analsysis of fives studies. Clin Ther 2002; 24:1384-1400

David M, Hamann C, Lichtenegger W.
Nitroglycerin-Pflaster als Therapieoption bei schwerer Dysmenorrhö: Resultate einer In-vitro-Untersuchung und klinische Erfahrung. Geburtsh Frauenheilk 2000 (10)

David M, Hamman C, Chen FC et al.
Comparison of the relaxation effect in vitro of nytroglycerin vs fenoterol on human myometrial strips. J Perinatal Med 2000; 38 (3): 232-42

Jansen JT. Noncontraceptive applications of the levonorgestrel intrauterine system. Current Women’s Health Report 2002; 2:417-22

EeC, Pirotta M. Primary dysmenorrhoea. Evidence for complementary medicine. Aus Fam Physiacian 2006; 35 (11):869

Neises M. Psychosomatik in der Frauenheilkunde. Geburtsh Frauenheilk 2004; 64:461-3

Istočni grijeh. http://www.wikipedia.hr

Amos WE, Khanna P. Life stress in spasmodic and congestive dysmenorrhea. Psychol Rep. 1985; 57(1):216-8

Larry JB, John LS, Ann CM. Dysmenorrhea and Personality. Journal of Personality Assessment.1978, 42(3):272-6 U. Holmlund . The experience of dysmenorrhea and its relationship to personality variables. Acta Psychiatrica Scandinavica. 1990; 82 (2): 182

Chesney MA, Tasto DL. The effectiveness of behavior modification with spasmodic and congestive dysmenorrhea. Behaviour, Research and Therapy. 1975; 13: 245-253.

Jarosch L, Grün A. Živi što jesi. Biblijski ženski likovi kao arhetipi. Kršćanska sadašnjost, Zagreb, 2006.

Balick L, Elfner L, May J, Moore D. Biofeedback Treatment of Dysmenorrhea. Biofeedback and Self-Regulation. 1982; 7(4): 499-520.

Weiner H, Mayer E. Der Organismus in Gesundheit und Krankheit. Auf dem Weg zu einem integrierten biomedizinischen Modell: Folgerungen für die Theorie der psychosomatischem Medizin. Psychoth med Psychol 1990; 49: 81-101

Barnard ND, Sciallie AR, Hurlock D, Bertron P.
Diet and Sex-Hormon Binding Globulin, Dysmenorrhea, and Premenstrual Symptoms. Obstet Gynecol 2000; 95 (2):245-50

Balbi C, Musone R, Meditto A et al. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. Eur J Obstet Gynecol Reprod Biol 2000; 91:143-8

Di Cintio E, Parazzini F, Tozzi L et al
. Dietary habits, reproductive and menstrual factors and risk of dysmenorrhoea. Eur J Epidemiol 1997; 13 (8): 925-30 Hudgins A. Niacin for Dysmenorrhea. Am. Pract. and Digest of Treat. 1952;3:892-893.

Hudgins A.
Vitamins P, C and Niacin for Dyomenorrhea Therapy. Western J Surgery and Gynecology. 1954; 62: 610-611.

Butler E, McKnight E.
Vitamin E in the treatment of primary dysmenorrhoea. Lancet, 1955; 1: 844-47.

Penland J, Johnson P.
Dietery calcium and manganese effects on menstrual cycle symptems. Am J Obstet Gynecol. 1993; 168: 1417-1423.

Harel L, et al.
Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol. 1996; 174(4): 1335-1338.

Campbell MA, McGrath, Patrick JD.
Non-pharmacologic Strategies Used by Adolescents for the Management of Menstrual Discomfort. Clinical Journal of Pain. 1999; 15(4):313-20

Nagata C, Hirokawa K, Shimizu N, Shimizu H.
Associations of menstrual pain with intakes of soy, fat and dietary fiber in Japanese women. Eur J Clin Nutr 2005; 59 (1): 88-92

Jones DY.
Influence of dietary fat on self-reported menstrual symptoms. Physiol Behav 1987; 40(4):483-7

Deutsch B.
[Painful menstruaction and low intake of n-3 fatty acids].Ugeskr laeger 1996; 158 (29):4195-8

Marel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3-polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. Am J Obstet Gynecol 1996; 174 (4):1335-8

Simopoulos AP. Omega 3 fatty acids in health in disease and growth and development. Am J Clin Nutr 1992; 54:438-63

Wilson ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorroea. Cochrane Database Sys Rev 2001 (3):CD002124

Ziaei S, Zakeri M, Kazemnejad A.
A randomised controlled trial of vitamin E in the treatment of primary dysmenorrhoea. BJOG 2005; 112:1164

Kryzhanovskii GN; Bakuleva LP, Luzina NL et al. [Endogenous opiod system in the realization of the analgesic effect of alpha-tocopherol in reference to algomenorrhoea] Biull Eksp Biol Med 1988; 105(2):148-50

Fugh-Berman A, Kronenberg F.
Complementary and alternative medicine (CAM) in reproductive-age women: a review of randomized controlled trials. Reprod Toxicol 2003; 17 (2): 137-52
Literatura